ZyVersa Therapeutics Inc (NASDAQ:ZVSA)’s traded shares stood at 0.37 million during the last session, with the company’s beta value hitting 0.78. At the close of trading, the stock’s price was $0.65, to imply a decrease of -10.47% or -$0.08 in intraday trading. The ZVSA share’s 52-week high remains $6.30, putting it -869.23% down since that peak but still an impressive 27.69% since price per share fell to its 52-week low of $0.47.

ZyVersa Therapeutics Inc (NASDAQ:ZVSA) trade information

After registering a -10.47% downside in the last session, ZyVersa Therapeutics Inc (ZVSA) has traded red over the past five days. The 5-day price performance for the stock is -0.41%, and 29.47% over 30 days. With these gigs, the year-to-date price performance is -38.47%.

ZVSA Dividends

ZyVersa Therapeutics Inc has its next earnings report out in July. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

We also have Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund as the top two Mutual Funds with the largest holdings of the ZyVersa Therapeutics Inc (ZVSA) shares. Going by data provided on Apr 30, 2025 , Fidelity Concord Street Trust-Fidelity Extended Market Index Fund holds roughly 18.08 shares. This is just over 0.38% of the total shares, with a market valuation of $11791.0. Data from the same date shows that the other fund manager holds a little less at 3.63, or 0.08% of the shares, all valued at about 2364.0.